Cargando…
Personalized Medicine in Mitochondrial Health and Disease: Molecular Basis of Therapeutic Approaches Based on Nutritional Supplements and Their Analogs
Mitochondrial diseases (MDs) may result from mutations affecting nuclear or mitochondrial genes, encoding mitochondrial proteins, or non-protein-coding mitochondrial RNA. Despite the great variability of affected genes, in the most severe cases, a neuromuscular and neurodegenerative phenotype is obs...
Autores principales: | Tragni, Vincenzo, Primiano, Guido, Tummolo, Albina, Cafferati Beltrame, Lucas, La Piana, Gianluigi, Sgobba, Maria Noemi, Cavalluzzi, Maria Maddalena, Paterno, Giulia, Gorgoglione, Ruggiero, Volpicella, Mariateresa, Guerra, Lorenzo, Marzulli, Domenico, Servidei, Serenella, De Grassi, Anna, Petrosillo, Giuseppe, Lentini, Giovanni, Pierri, Ciro Leonardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182050/ https://www.ncbi.nlm.nih.gov/pubmed/35684429 http://dx.doi.org/10.3390/molecules27113494 |
Ejemplares similares
-
Targeting Penicillium expansum GMC Oxidoreductase with High Affinity Small Molecules for Reducing Patulin Production
por: Tragni, Vincenzo, et al.
Publicado: (2020) -
FAD/NADH Dependent Oxidoreductases: From Different Amino Acid Sequences to Similar Protein Shapes for Playing an Ancient Function
por: Trisolini, Lucia, et al.
Publicado: (2019) -
Modeling SARS-CoV-2 spike/ACE2 protein–protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context
por: Tragni, Vincenzo, et al.
Publicado: (2022) -
The Bacterial Protein CNF1 as a Potential Therapeutic Strategy against Mitochondrial Diseases: A Pilot Study
por: Fabbri, Alessia, et al.
Publicado: (2018) -
COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help
por: Lentini, Giovanni, et al.
Publicado: (2020)